发明名称 Crystalline form of a drug
摘要 Atrasentan Hydrochloride Crystalline Form 3, compositions containing it and methods of treatment of diseases and inhibition of adverse physiological events using it are disclosed.
申请公布号 US9051301(B2) 申请公布日期 2015.06.09
申请号 US200511229922 申请日期 2005.09.19
申请人 AbbVie Inc. 发明人 Zhang Geoff G. Z.
分类号 C07D207/12;C07D405/10 主分类号 C07D207/12
代理机构 代理人 Ward Michael J.
主权项 1. Atrasentan Hydrochloride Crystalline Form 3 characterized, when measured at about 25° C. with Cu-Kα radiation, by a powder diffraction pattern with peaks having respective 2θ values of about 6.7°, 8.4°, 15.6°, 18.0°, 18.5°, 19.8°20.6° and 21.95°.
地址 North Chicago IL US